Glaukos's change in receivables for the quarter that ended in Mar. 2025 was $-12.3 Mil. It means Glaukos's Accounts Receivable
increased by $12.3 Mil
from Dec. 2024 to Mar. 2025 .
Glaukos's change in receivables for the fiscal year that ended in Dec. 2024 was $-22.0 Mil. It means Glaukos's Accounts Receivable
increased by $22.0 Mil
from Dec. 2023 to Dec. 2024 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Glaukos's Days Sales Outstanding for the
three
months ended in Mar. 2025 was 61.19.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Glaukos's liquidation value for the
three
months ended in Mar. 2025 was $179.9 Mil.
Glaukos Change In Receivables Historical Data
The historical data trend for Glaukos's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-27.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glaukos (NYSE:GKOS) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Glaukos's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glaukos Change In Receivables Related Terms
Thank you for viewing the detailed overview of Glaukos's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GKOS has been successfully added to your 